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Basal cell carcinomas and normal skin were exam-
ined in relation to the abnormal expression of
gangliosides. The content of gangliosides with 9-O-
acetylated sialic acids of 26 sample pairs was
analyzed by a microtiter assay using in¯uenza C
virus as well as by ¯uorimetric high-performance
liquid chromatography of the sialic acids released.
The 9-O-acetylation levels were signi®cantly (up to
56-fold) higher in basal cell carcinoma tissues than in
the skin surrounding basal cell carcinomas. Slightly
elevated amounts of O-acetylated gangliosides were
also seen in the skin marginal to the basaliomas. The
ganglioside composition of four sets of pooled
samples of basal cell carcinoma and one pool of
normal skin were studied by high-performance thin-
layer chromatography and immune high-perfor-
mance thin-layer chromatography using monoclonal
antibodies against 9-O-acetyl GD3. The lipid-bound
sialic acid content of normal skin was 0.029 mg dry
weight, whereas in nodular basal cell carcinomas it
was approximately twice as much. Several O-acety-
lated sialic acids were seen by high-performance
liquid chromatography analysis, but N-acetyl-9-O-
acetylneuraminic acid prevailed. Only in the tumor
ganglioside fraction, a small amount of N-glycolyl-
neuraminic acid was found. The 9-O-acetylated
gangliosides with mainly 9-O-acetyl-GD3 can be
considered as tumor-associated antigens or markers
for basal cell carcinomas. This ®nding about tumor-
associated carbohydrates may contribute to new
strategies in current tumor diagnosis and therapy.
Key words: high-performance liquid chromatography/in¯u-
enza C virus assay/N-acetyl-9-O-acetylneuraminic acid/
N-glycolylneuraminic acid/O-acetylated GD3/tumor-asso-
ciated antigen. J Invest Dermatol 116:254±260, 2001
G
angliosides comprise a major group of cell surface
molecules, which participate in such processes as
intercellular recognition, cell growth, and differen-
tiation (Zeller and Marchase, 1992; Hakomori,
1998). As typical for plasma membrane constituents,
they consist of a lipophilic ceramide portion and a hydrophilic
carbohydrate chain with at least one sialic acid as the characteristic
component. This glycosylation represents the actual receptor
structure in biologic recognition (Schauer et al, 1988), whose
composition varies widely (Wiegandt, 1985).
Over the past years several gangliosides have been found to
behave as tumor-associated antigens and were tested for their use as
target molecules in the diagnosis and treatment of human cancer,
e.g., such as GM2 and GD3 for metastasized melanoma (Livingston
et al, 1994; Ritter et al, 1995; Nasi et al, 1997; Takahashi et al,
1999), or GD2 for neuroblastoma (Sondel and Hank, 1997). As to
human skin, research did focus on melanoma, but not much is
known about the ganglioside pro®le of skin itself (Gray and
Yardley, 1975; Hamanaka et al, 1983; Nakakuma et al, 1992).
Previously, Paller et al (1992) examined the ganglioside composi-
tion of basalioma by thin-layer chromatography; however,
regarding O-acetylated gangliosides, they looked speci®cally for
9-O-acetyl GD3 by the use of corresponding antibodies and found
a signi®cant increase of this glycolipid. As for various types of
neoplastic tissue pronounced changes in the O-acetylation of
ganglioside-bound sialic acids have been demonstrated (Cheresh
et al, 1984; Reid et al, 1984; Varki, 1992), we were interested in the
overall extent of O-acetylation of gangliosides in normal human
skin compared with that of basal cell carcinoma (BCC) as its most
frequent tumor. The concentration of gangliosides in non-neural
tissue is rather low (Svennerholm, 1984), and for analysis very
sensitive methods are needed. Therefore, in particular, we used
mainly the in¯uenza C virus assay developed by Zimmer et al
(1992), which allows the detection of 9-O-acetylated sialic acids
irrespective of their carrier molecule.
MATERIALS AND METHODS
Materials Bovine milk 9-O-acetyl GD3 standard and mouse anti-9-O-
acetyl GD3 monoclonal antibody (MoAb) were kind gifts of Toshiaki
Suguri (Snow Brand Milk Products, Tokyo, Japan). Neu5Ac and
gangliosides from bovine brain were purchased from Sigma (Deisenhofen,
Germany), as well as goat anti-mouse alkaline phosphatase-conjugated
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MoAb, hydroxyalcoxypropyldextran, and polystyrene 96-well microtiter
plates. Fractogel, high-performance thin-layer chromatography (HPTLC)
silica gel 60 plates and high-performance liquid chromatography (HPLC)
solvents were from Merck (Darmstadt, Germany).All other chemicals were of
reagent grade or better, and were from commercial sources.
Human tissues BCC tissues and surrounding normal skin were obtained
from patients who were operated on at the Department of Dermatology,
University Kiel, Germany. Most of these tissues were stored in paraf®n and
chosen according to their histopathologic diagnosis. Twenty-six pairs of
tumor samples, diagnosed as nodular BCC (with at least 10% of the biopsy
consisting of neoplastic cells) and tumor-free surrounding skin,
respectively, were subjected to a microtiter assay to detect 9-O-
acetylated gangliosides. For this assay a further 12 samples of normal
human skin were obtained at excision and immediately stored in methanol
at 4°C until further processing. For HPLC analysis, virus-HPTLC, and
immuno-HPTLC, four sets of pooled BCC samples (to a total of
approximately 460 mg for each extraction), one pool of BCC
surrounding tissues, and normal skin samples each were collected. Tumor
specimens and normal tissues were trimmed from fat tissue, homogenized
on ice, lyophilized, and stored at ±80°C until extraction. All lyophilized
tissues were standardized by dry weight prior to extraction.
Virus In¯uenza C virus (strain Johannesburg/1/66), grown in
embryonated chicken eggs, was donated by Prof. Dr G. Herrler (Institut
fuÈr Virologie, TieraÈrztliche Hochschule, Hannover, Germany). Viruses
were concentrated from the allantoic ¯uid by centrifugation and
resuspended in phosphate-buffered saline (PBS, pH 7.2), consisting of
137 mM NaCl, 3 mM KCl, 8.5 mM Na2HPO4 3 2H2O, 1.5 mM
KH2PO4, containing 1% bovine serum albumin (BSA). Aliquots were
stored frozen at ±80°C.
The hemagglutination assay was carried out in round-bottom microtiter
plates. Serial 3-fold virus dilutions in 1% BSA±PBS were prepared and to
25 ml of each dilution were added 25 ml of a 0.5% suspension of chicken
erythrocytes. After 1 h at 4°C, the hemagglutination activity (HAU per ml)
was determined as the reciprocal value of the highest dilution causing
complete agglutination.
Extraction of gangliosides Total gangliosides were extracted from
tissue samples and puri®ed based on the method described by Kundu and
Suzuki (1981). In brief, homogenized tissue samples were mixed with
45 ml solvent per mg dry weight and glycolipids extracted successively by
sonication (at 4°C for 10 min) and centrifugation (10,000 3 g, at 4°C for
10 min) using C/M/W (1:1:0.2, vol/vol/vol), followed by C/M/W
(1:2:0.1, vol/vol/vol), C/M (1:1, vol/vol), and C/M (2:1, vol/vol). After
each centrifugation, the supernatant was removed as the extract and the
residue was re-extracted. The combined extracts were evaporated,
redissolved in methanol, and applied to Fractogel ion exchange columns
(bed volume 2.3 ml per g dry weight of original sample) (MuÈthing and
Unland, 1994), which had been equilibrated before with 5 volumes of
methanol containing 1 M NH4OAc and then with 5 volumes of methanol.
Most neutral lipids were washed out with 5 volumes of methanol. Acidic
lipids were then eluted with 5 volumes of methanol containing 0.6 M
NH4OAc and collected on ice. The solvent was evaporated in vacuo at a
maximal bath temperature of 25°C.
Salt in the extracts was removed using reversed-phase columns ®lled
with hydroxyalcoxypropyldextran (bed volume 0.5 g per g original dry
weight). For this purpose, the samples were redissolved in at least 2 ml of
0.1 M KCl/methanol (1:1) (5 ml per g original tissue dry weight) with
sonication and applied to columns, previously equilibrated by washing with
7 ml C/M (1:2), 3 ml methanol, 7 ml H2O, and 3 ml H2O containing
0.1 M KCl. After washing with 12 ml H2O, the gangliosides were eluted
with 2 ml methanol and 20 ml C/M (1:2). The puri®ed gangliosides were
concentrated by evaporation and stored at ± 80°C.
HPTLC Gangliosides were separated on glass-backed 10 3 10 cm
HPTLC plates in C/M/0.2% aqueous CaCl2 (60:40:9, vol/vol/vol)
running solvent. Sialic acid containing compounds were visualized by
staining with the orcinol/Fe3+/HCl reagent (BoÈhm et al, 1954).
De-O-acetylation Alkaline hydrolysis of sialic acids (free or ganglioside-
bound) was carried out with 25% aqueous ammonia for 2 h at room
temperature. Saponi®cation was stopped by adding distilled water, and
ammonia was removed by lyophilization.
Virus assay on microtiter plate 9-O-Acetylation was analyzed as
described by Zimmer et al (1992). This assay was performed on microtiter
plates (black, ¯at-bottomed). Ganglioside samples were dissolved in 100 ml
methanol, added to each well, and the solvent allowed to evaporate
overnight at room temperature. Remaining binding sites on the
polystyrene were blocked by the application of 2% BSA±PBS (200 ml per
well) for 2 h at room temperature. Then these wells were washed twice
with 200 ml 0.05% Tween-20 PBS. Virus suspension (100 ml per well) in
2% BSA±PBS with an acetylesterase activity of 1±2 mU was added and
allowed to bind for 1.5 h at 4°C. The wells were washed three times as
above to remove unbound virus and incubated with 100 ml of 60 mM 4-
methylumbelliferyl acetate in PBS for 45 min at 37°C. The reaction was
stopped by adding 100 ml 70% ethanol. The amount of released 4-
methylumbelliferone was assayed in a Fluorolite 1000 microtiter plate
¯uorimeter (Dynatech, Deutschland GmbH, Denkendorf, Germany) at
wavelengths of 365 nm for excitation and 450 nm for emission. Negative
control was the incubation of in¯uenza C virus with O-deacetylated
samples.
Statistical analysis of virus microtiter assay The two-sided U test
(Mann and Whitney, 1947) was used for the analysis of the 9-O-acetylation
level (measured as ¯uorescence intensities) of BCC and normal human skin
samples. The paired samples of BCC and BCC surrounding skin were
compared by the two-sided Wilcoxon pair difference test (Sachs, 1992).
HPTLC virus overlay assay Detection of 9-O-acetylated gangliosides
separated on HPTLC plates (see above) was performed using in¯uenza C
virus (Zimmer et al, 1992). Brie¯y, the dried plates were ®xed by
chromatographing in a freshly prepared solution of hexane saturated with
polyisobutylmethacrylate (Plexigum P28, RoÈhm, Darmstadt, Germany).
After thorough drying, the plates were dipped in PBS and then immersed
in 1% BSA±PBS for 2 h at room temperature. After decanting the buffer
and two wash steps with PBS, the plates were overlayed with 1% BSA±PBS
containing virus with a hemagglutination activity of 100 HAU per ml. The
plates were covered with a piece of para®lm and the virus allowed to bind
for 1.5 h at 4°C. Unbound virus was removed by three wash steps (0.1%
Tween-20-PBS) of 5 min each at 4°C, and then a solution of 10 mg 2-
naphthyl acetate (Sigma) and 70 mg 4-chloro-2-methylbenzene-diazonium
salt (FastRed TR-salt, Sigma) in 50 ml PBS was applied. After 1 h at room
temperature, the reaction was stopped by dipping the plates in distilled
water and drying.
HPTLC immunostaining 9-O-Acetylated GD3 on HPTLC plates was
detected by a method of Bethke et al (1986). After the chromatograms had
been ®xed by Plexigum P28 and blocked by BSA as described above, 1:200
diluted MoAb from mouse (against 9-O-acetylated GD3) in 1% BSA±PBS
was added and spread over the whole chromatogram by covering it with a
piece of para®lm. After 1.5 h at room temperature, unbound antibody was
washed away in three steps (0.05% Tween-20-PBS) of 5 min each under
shaking. The chromatograms were incubated with an alkaline phosphatase-
labeled secondary antibody from goat at a dilution of 1:1000 in 1% BSA±
PBS for 1.5 h at room temperature and then washed as above. A last wash
step of 10 min was done using glycine buffer (100 mM glycine, 1 mM
ZnCl2, 1 mM MgCl2, NaOH till pH 10.4). The antigen±antibody complex
was visualized by covering the plates with a solution of 200 ml NBT/BCIP
reagent (Boehringer Mannheim, Germany) in 10 ml Tris buffer (100 mM
Tris, 100 mM NaCl, 50 mM MgCl2, HCl till pH 9.5). After 10 min at
room temperature, the reaction was stopped by rinsing the plates with
distilled water and drying. Binding sites were stained as purple bands.
Analysis of sialic acids Colorimetric quantitation of sialic acids in
microscale was carried out using the orcinol/Fe3+/HCl reagent as described
by Schauer (1978). For qualitative analysis, sialic acids were released from
glycosidic linkages by a two-step acid hydrolysis at 80°C with 2 M
propionic acid for 4 h and 0.1 M HCl for 1 h (Schauer, 1978; Mawhinney
and Chance, 1994; Reuter and Schauer, 1994).
Lyase treatment Cleavage of aliquots of the sialic acids liberated was
achieved by incubation with 25 mU sialate lyase (EC 4.1.3.3) from
Clostridium perfringens (Sigma) in 100 ml phosphate buffer (250 mM
K2HPO4, 250 mM KH2PO4, pH 7.2) for 1 h at 37°C (Reuter and
Schauer, 1994). The reaction was stopped by heating at 96°C for 5 min and
the sample was lyophilized.
HPLC Lyophilized samples of free sialic acids were dissolved in 10 ml 2 M
acetic acid and with 50 ml solution of 7 mM 1,2-diamino-4,5-
methylenedioxybenzene, 0.75 M b-mercaptoethanol and 18 mM sodium
hydrosul®te heated at 56°C for 1 h in the dark (Hara et al, 1989). The
reaction was stopped by cooling on ice. 1,2-diamino-4,5-
VOL. 116, NO. 2 FEBRUARY 2001 SIALIC ACID O-ACETYLATION IN BASALIOMA GANGLIOSIDES 255
methylenedioxybenzene-derivatized sialic acids were separated by
reversed-phase chromatography on a LiChrospher 100 RP-18 column
(250 3 4 mm, particle size 5 mm, Merck) using acetonitrile/methanol/
water (9:7:84, vol/vol/vol) as mobile phase (Reuter and Schauer, 1994). A
¯ow rate of 1 ml per min was achieved with a Spectro¯ow pump (Kratos
Analytical, Ramsey, NJ). Elution was monitored with a Merck-Hitachi D-
6000 HPLC ¯uorescence detector at wavelengths of 373 nm for excitation
and 448 nm for emission. The sialic acid nature of the HPLC peaks was
determined by a second HPLC run with lyase-treated aliquots (see above)
and by the use of authentic sialic acid standards, respectively. O-Acetylation
was proved by a HPLC run of de-O-acetylated samples. For the retention
times of different sialic acids using this method see Schauer and Kamerling
(1997).
RESULTS
Detection limits With regard to the low content of O-
acetylated gangliosides in keratinocytes, it was important to know
the sensitivity of the analytic methods used (Table I). For the virus
microtiter assay, the detection limit was determined by serial
dilution of 9-O-acetyl GD3. Thereby 10 ng of this ganglioside or
6.3 pmol Neu5,9Ac2, respectively, have been found to be the
minimal detectable amounts. The HPLC analysis allowed the
detection of sialic acids in amounts as low as 1.2 ng or 3.9 pmol;
however, this ®gure represents a just visible peak at a HPLC
chromatogram: due to necessary preparations and reference HPLC
runs a sample had to contain at least 6 ng sialic acids. HPTLC
sensitivity was evaluated visually. At 5 mm lanes, a minimum of
0.5 mg 9-O-acetyl GD3 (containing 0.3 nmol Neu5,9Ac2) had to
be applied to achieve bands visible by the virus overlay assay. The
antibody overlay assay reacted 20-times more sensitive, here 25 ng
(0.017 nmol) 9-O-acetyl GD3 were suf®cient for visible staining.
9-O-Acetyl ganglioside content of BCC and normal
skin Gangliosides were submitted to virus microtiter assay and
9-O-acetylation determined as ¯uorescence intensity (E per mg
sialic acid). 9-O-Acetylation of corresponding samples (BCC and
surrounding skin from the same patient) was compared,
furthermore unrelated samples of BCC and normal skin. As
shown in Fig 1, the median ¯uorescence intensity of BCC tissue
was found to be signi®cantly higher than that in BCC surrounding
skin (252.6 Û 401.7 Û 532.0 E per mg sialic acid (n = 26) vs
56.5 Û 156.5 Û 210.2 E per mg sialic acid (n = 25), 0.1% niveau).
In 20 of 26 BCC samples the detected levels of ¯uorescence were
up to 56-fold higher than those of their direct surrounding.
Ganglioside extracts from normal skin also showed some increase in
¯uorescence intensity compared with their de-O-acetylated
references. Their median ¯uorescence intensity was signi®cantly
lower (1.1 Û 6.4 Û 43.7 E per mg sialic acid (n = 12), 0.1% niveau)
than that of the BCC samples. The virus binding was abolished by
prior saponi®cation of the gangliosides.
9-O-Acetylation patterns by TLC Gangliosides were
separated on HPTLC plates and tested for 9-O-acetylation by
virus overlay and the use of MoAb against 9-O-acetyl GD3. To
obtain large enough amounts of samples to be analyzed this way,
gangliosides were isolated from pooled tumor and skin samples,
Figure 1. Content of 9-O-acetylated gangliosides, expressed indir-
ectly as relative ¯uorescence intensity (E). The levels of esterase
¯uorescence were determined by the in¯uenza C virus microtiter assay.
The distribution of ¯uorescence levels is shown by box plots, displaying the
10th, 25th, 50th, 75th, and 90th percentiles of a variable (see Mann and
Whitney, 1947). The individual top and bottom dots represent the most
extreme values. The basalioma samples (B) had a signi®cantly higher
¯uorescence intensity than their direct surrounding tissue (S) and normal
human skin (N).
Figure 2. Orcinol-stained thin-layer chromatography of ganglio-
sides extracted from human basalioma. Gangliosides were separated
on silica HPTLC plates for 50 min in C/M/0.2% CaCl2 3 H2O (60:40:9,
vol/vol/vol), standards from bovine brain (St) were run concurrently.
Basalioma ganglioside bands (B) are numbered 1±7. Only the gangliosides
stained reddish, in contrast to the highest migrating, diffused bands, not
representing such glycolipids. At positions 3 and 5 are migrating standard
GD3 and 9-O-acetyl-GD3, respectively.
Table I. Detection limits of the analytical methods
employed for the ganglioside 9-O-acetyl GD3 and its
Neu5,9Ac2 component, respectively
Method 9-O-acetyl GD3 Neu5,9Ac2
(ng)
(ng) (pmol)
HPLC analysis 5 3.4 1.2a
Microtiter assay 10 6.3 2.2
Antibody overlay 25 15.8 5.5
Virus overlay 500 316.5 111.1
aMinimum amount to be injected resulting in a clearly visible peak.
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respectively. Prior to the overlay assays, a ganglioside extract of
pooled basaliomas was submitted to orcinol staining. Seven purple
bands were visualized by this reagent (Fig 2). By their
chromatographic mobility three of these (1, 2, 4) were consistent
with the gangliosides GT1b, GD1a, and GM1, respectively. A
further two bands were detected close behind and ahead of the
suggested GM1. The former (3) is likely to be the less polar
ganglioside GD3, whereas the latter (5) could be the more polar 9-
O-acetyl GD3 or GM2. The remaining two bands (6, 7) were fast
migrating, pointing to gangliosides with one sialic acid, such as
GM2 or GM3. The upper, cloudy structures had not the typical
reddish stain due to the orcinol reagent, but stained brown±yellow
and, therefore, may represent phospholipids.
Whereas the main gangliosides GT1b, GD1a, and GM1 do not
constitute viral receptors, other minor compounds were distin-
guished by the virus overlay assay. Ganglioside extracts of
basaliomas remarkably differed from that of normal skin by the
complete absence of visible viral binding in the latter. The BCC
extracts bound virus in the form of three to four bands, with 9-O-
acetyl-GD3 as upper band (a) prevailing, as shown in Fig 3(A, lanes
4±6). This prominent ganglioside comigrated with the 9-O-acetyl
GD3 reference (lane 8) and was detectable by MoAb against 9-O-
acetyl GD3 (Fig 3B). In three of the four BCC pools (Fig 3A, lanes
4, 5, 7) a similar strongly virus-stained band of unknown nature
was visible below 9-O-acetyl GD3 (b), which did not bind the
MoAb (Fig 3B). The identity of the slowest-migrating, faint bands
(c, d) in lanes 4±6 (Fig 3A) could also not be determined. A further
three spots were visible ahead of 9-O-acetyl GD3; however, these
showed a yellow±brown color instead of the typical reddish staining
and thus do not represent glycolipids with 9-O-acetylated sialic
acids (compare also Fig 2). The staining of these fast-migrating
compounds is not due to a speci®c in¯uenza C virus binding, but
may be derived from the esterase reagents (Zimmer et al, 1992).
These bands also became faintly visible by immunostaining
(Fig 3B). In the gangliosides of BCC surrounding tissue a band
of minor intensity was found by virus staining (lane 3, Fig 3A) that
had the same mobility as reference ganglioside 9-O-acetyl GD3 and
also immunostaining (lane 3, Fig 3B, marked by an arrow) was
slightly positive. The identity of these bands with compounds
containing Neu5,9Ac2 was con®rmed by saponi®cation prior to
staining, which resulted in the disappearance of these bands.
HPLC detection of O-acetylated sialic acids and Neu5Gc in
basalioma gangliosides Ganglioside-derived sialic acids were
investigated by ¯uorescent HPLC after release by acid hydrolysis.
The HPLC pro®les showed many peaks. Allocation to individual
sialic acids was based on their retention time relative to Neu5Ac
(RNeu5Ac of 1.00), comparison with standard sialic acids and the
effect of lyase treatment and saponi®cation of reference samples run
in parallel.
Neu5Ac dominated in all probes analyzed. Ganglioside extracts
of all four BCC pools contained a peak eluted at RNeu5Ac of 1.64 or
1.65, which disappeared after lyase treatment and saponi®cation. By
this behavior and its retention time this peak is consistent with the
9-O-acetylated sialic acid Neu5,9Ac2. A further two peaks were
eluted at RNeu5Ac of about 1.19 and 1.40, respectively. They were
no longer detected after saponi®cation, indicating the presence of
an O-acetyl group. They represent Neu5,7Ac2 and Neu5,8Ac2,
according to analytical data presently obtained in our laboratory
with standards from bovine submandibular glands and according to
retention times and mass spectrometric analyses described in the
literature (Klein et al, 1997; Schauer and Kamerling, 1997;
Vandamme-Feldhaus and Schauer, 1998). In two of the four
basalioma pools a small peak with a short retention time
(RNeu5Ac = 0.78) was found. It changed only slightly by alkaline
treatment, but disappeared by lyase action, thus suggesting its
identity as Neu5Gc (Fig 4).
The analysis of BCC surrounding tissues was characterized by a
major peak of Neu5Ac and four compounds in minor quantities
(< 3.4%). The small one ahead of Neu5Ac (RNeu5Ac = 0.79)
Figure 3. Detection of 9-O-acetylated gangliosides by TLC. After
chromatography on silica gel HPTLC plates in C/M/0.2% CaCl2 3 H2O
(60:40:9, vol/vol/vol), the plates were overlayed with in¯uenza C virus (A)
or MoAb against 9-O-acetyl GD3 (B), respectively. Standard gangliosides
from bovine brain, 75 ng 9-O-acetyl GD3, and 25 mg GD3 (lanes 1, 8 and
9, respectively), total gangliosides from normal human skin (lane 2,
corresponding to 2 mg sialic acid per lane in A and 1.2 mg per lane in B),
total gangliosides from BCC surrounding tissue (lane 3, corresponding to
1.5 mg sialic acid per lane in A and 0.8 mg per lane in B), total gangliosides
from different basalioma pools (lanes 4±7, corresponding to 1.5±4 mg sialic
acid per lane in A and 0.9±2 mg per lane in B). The position of 9-O-acetyl
GD3 is marked by a and that of slower migrating, partially very faint, bands
by b, c and d. The position of a hardly visible 9-O-acetyl GD3 band of lane
3 in B is indicated by an arrow. In lanes 2 (A, B), from normal skin, no
staining occurred by both techniques, demonstrating the absence of O-
acetylated gangliosides. The reduced distance of the band(s) in B, lane 6,
cannot be explained and may be due to impurities. The spots above 9-O-
acetyl GD3 do not represent gangliosides. Note that in the gangliosides
from bovine brain three bands are stained by the virus (A, lane 1), which
may represent O-acetylated species.
Figure 4. HPLC of sialic acids from ganglioside extracts of pooled
basaliomas. Derivatization of the sialic acids with 1,2-diamino-4,5-
methylenedioxybenzene and the conditions of RP-HPLC are described in
Materials and Methods. (A) Original chromatogram; (B) section of the sialic
acid pro®le at higher resolution. Peak identi®cation (for details see the
text): 1,2,7, impurities from the reagent; 3, Neu5Gc; 4, Neu5Ac; 5,
Neu5,7Ac2; 6, Neu5,9Ac2.
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represents Neu5Gc, whereas elution time and alkali lability of two
further peaks (RNeu5Ac of 1.19 and 1.64) shows the presence of
Neu5,7Ac2 and Neu5,9Ac2, respectively. At chromatography of
sialic acids from the normal skin pool, no peak at RNeu5Ac = 0.79
was visible. Besides Neu5Ac, several minor peaks eluted. With the
exception of Neu5,8Ac2 eluting at RNeu5Ac of 1.42, these could
not unequivocally be identi®ed due to the presence of impurities
assumed by incomplete destruction with alkali or the lyase.
The sialic acid content of the tissue probes was determined by
comparison with pure N-acetylneuraminic acid. The following
data relate to the dry weight of the analyzed tissue samples. The
content of ganglioside-derived Neu5Ac of basaliomas was found to
be higher than that of BCC surrounding skin (range of 43.2±
55.9 ng per mg vs 31.4 ng per mg) and that of normal human skin
(18.8 ng per mg) (Table II).
In BCC ganglioside extracts Neu5Ac represents between 93 and
94% total sialic acids in the mixture (Table II). Neu5,9Ac2 was
detected as 2.7±5.1% of the Neu5Ac content. In BCC surrounding
tissue on average 3.1% Neu5,9Ac2 was found. The values for
Neu5,7Ac2 were between 1.3 and 3.6%. With the exception of
normal skin, the relative amount of Neu5,8Ac2 was much smaller
and present only in two of the four basalioma pools.
DISCUSSION
Neoplastic tissues differ from their normal origins in many ways.
We have used mainly in¯uenza C virus to identify and compare the
content of O-acetylated gangliosides of 26 human basaliomas with
their surrounding tissue and with 12 normal skin samples.
Our results show a signi®cantly increased amount of O-
acetylation in the basalioma ganglioside extracts (Fig 1). For 20
of the 26 biopsy pairs the 9-O-acetylation level was up to 56-fold
higher in basalioma compared with their direct surroundings.
Considering the only 10±20% share of neoplastic cells in the
analyzed basalioma samples, this difference becomes even more
impressive and meets the ®ndings of Paller et al (1992) and
Heidenheim et al (1995) based on immunologic and histologic
methods. Cheresh et al (1984) described increased levels of O-
acetylated gangliosides in melanomas compared with normal
melanocytes. A higher level of O-acetyl GD3 (and O-acetyl-
GT3) was also found in human breast cancer (Marquina et al, 1996),
as well as in murine neuroblastoma cells (Ariga et al, 1995), showing
that the expression of these glycolipids and perhaps also of the
corresponding sialate-O-acetyltransferase is increased in tumors of
neuroectodermal origin. In contrast, Reid et al (1984) and Cor®eld
et al (1999) reported that the content of O-acetylated sialic acids in
glycoproteins was lowered in colon cancer. A change in the degree
of O-acetylation seems to be characteristic of malignantly
transformed cells; however, this has been observed as well in
physiologically developing tissues when compared with mature
tissues (Schauer, 1997). Evidence is accumulating that the
production of high quantities of O-acetylated gangliosides,
especially 9-O-acetyl-GD3, is related to rapid growth, both under
physiologic and pathologic conditions (Heidenheim et al, 1995;
Marquina et al, 1996; Araujo et al, 1997; Gocht et al, 1998; BirkleÂ
et al, 1999; Farrer and Quarles, 1999). Thus, the immunoreactivity
with CDw60 antibodies (speci®c for 9-O-acetyl GD3) in basalioma
was highest in the marginal, fastest growing zone of the tumor, in
contrast to the more central parts (Heidenheim et al, 1995).
Furthermore, the growth of hamster melanoma cells was much
slower after transfection of the sialate-9-O-acetylesterase cDNA,
which resulted in a decreased O-acetyl-GD3 content of the tumor
cells. How this ganglioside mediates this acceleration of growth is
unknown. One reason is that O-acetylated sialic acids hinder the
adhesive processes mediated by sialic acid-recognizing proteins on
the membranes of adjacent cells, which may regulate cell and tissue
growth via signaling processes and possibly contact inhibition thus
facilitating cell migration. Such a negative in¯uence of sialic acid
O-acetyl groups on sialic acid recognizing proteins (``Siglecs'') and
corresponding recognition phenomena has been observed in
various cells (Shi et al, 1996; Kelm and Schauer, 1997). Zeng et al
(1999) assume a stimulating effect of GD3 and its O-acetylated
derivative on the angiogenesis of the tumor.
In this study, the overall ganglioside pattern constituted a side
issue; however, the major gangliosides in the analyzed single pool
of basalioma biopsies were GT1b, GD1a, GM1, and 9-O-
acetylated GD3 (Fig 2), which differs signi®cantly from patterns
in normal skin, where GM3 and GD3 dominated (Hamanaka et al,
1983). Paller et al (1992) reported GM3, GD3, GD1a and 9-O-
acetyl GD3 to be the major ganglioside components in basaliomas.
Regarding the ganglioside content, we detected a 2.5-fold
higher level of lipid-bound sialic acids in basaliomas (48.8 ng per
mg dry weight) compared with that in normal human skin (18.8 ng
per mg) (Fig 5), whereas Paller et al (1992) described a 3.5-fold
increase. Our ganglioside content determined for normal skin was
in the same range as reported by Svennerholm (1984). Differences
between our values and Paller's studies may be due to several
factors: (i) use of different extraction procedures may result in
varying ganglioside contents as well as varying proportions of
extracted O-acetylated gangliosides; (ii) we determined the amount
Table II. Content of sialic acids from the ganglioside extracts of four basalioma pools (B1-B4), tumor-surrounding tissue and
normal skin, determined by HPLC and related to the dry weight of the original samplesa
Sample pools Neu5Ac Further peaksb Alkali Other sialic Content
(ng per mg) (RNeu5Ac) labile acids (%Neu5Ac)
BCC B1 55.9 0.78 ± Neu5Gc 1.1
1.21 + Neu5,7Ac2 3.6
1.65 + Neu5,9Ac2 2.7
BCC B2 48.1 1.19 + Neu5,7Ac2 1.5
1.42 + Neu5,8Ac2 0.6
1.64 + Neu5,9Ac2 5.1
BCC B3 46.5 1.20 + Neu5,7Ac2 3.2
1.38 + Neu5,8Ac2 1.0
1.64 + Neu5,9Ac2 3.3
BCC B4 43.2 0.79 (±) Neu5Gc 1.1
1.19 + Neu5,7Ac2 1.3
1.64 + Neu5,9Ac2 4.3
BCC 31.4 0.79 ± Neu5Gc 1.0
surrounding 1.19 + Neu5,7Ac2 3.3
tissue 1.64 + Neu5,9Ac2 3.1
Normal skin 18.8 1.42 + Neu5,8Ac2 4.7
aRetention times are each related to that of Neu5Ac (RNeu5Ac = 1.00). Only peaks were denominated which could be saponi®ed and/or were susceptible to lyase action.
bPeak representing > 0.5% of the Neu5Ac peak.
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of O-acetylated gangliosides by HPLC analysis of the lipid-bound
sialic acid content (3% for Neu5,9Ac2), whereas Paller et al (1992)
measured the percentage of each ganglioside by densitometry after
TLC (13% for 9-O-acetyl GD3); and (iii) in this study a
comparison of individual sample pairs from the same patient was
intended in contrast to the exclusive analysis of pooled tissue
samples by Paller et al (1992).
The in¯uenza C virus assay on TLC of basalioma extracts
showed that O-acetylation is distributed among at least three
different kinds of gangliosides (Fig 3). The major band comigrated
with the 9-O-acetyl GD3 reference. Immunostaining con®rmed its
identity as 9-O-acetyl GD3, which has been reported to be a
tumor-associated antigen in human malignant melanoma (Cheresh
et al, 1984). The band close to 9-O-acetyl GD3, most pronounced
in lane 4 of Fig 3(A), is most likely a related form with a different
fatty acid in its ceramide portion, although it does not react with
the antibody. In order to elucidate the structures of these unknown
O-acetylated gangliosides, as well as of the other, minor ganglio-
sides visible in Fig 2, larger amounts of basaliomas should be
collected and their glycolipids analyzed by, e.g., mass spectrometry
or nuclear magnetic resonance spectroscopy. In contrast to
antibodies, only the virus assays enable the simultaneous detection
of various gangliosides with 9-O-acetylated sialic acid, as only by
these tests this kind of sialic acid can be detected irrespective of the
nature of the glycoconjugate to which it is linked (Hubl et al, 2000).
It has to be noted that gangliosides with O-acetylated sialic acids
other than Neu5,9Ac2 would not be stainable by this virus assay
(Harms et al, 1996; Schauer et al, 2001). Only HPLC analysis of
sialic acids liberated from the puri®ed ganglioside fractions gave
hints to the existence of such glycolipids, i.e., containing
Neu5,7Ac2 and Neu5,8Ac2. Their analysis also awaits other
physicochemical methods.
The HPLC analysis from basalioma revealed the lipid-bound
sialic acids Neu5Ac with the O-acetylated forms Neu5,7Ac2,
Neu5,8Ac2, and Neu5,9Ac2 as well as Neu5Gc (Table II). The
occurrence of Neu5,9Ac2 has been described previously by Paller
et al (1992) by using an antibody against Neu5,9Ac2-containing
GD3, but no direct analysis of this sialic acid isolated from this
tumor has been carried out so far. Furthermore, other O-acetylated
sialic acids as well as Neu5,7Ac2 in the gangliosides from the
tumor-surrounding tissue are new ®ndings. The glycolipid fraction
of basalioma also revealed the presence of Neu5Gc. For human
tissues the putative expression of a ganglioside species containing
Neu5Gc is rather unusual (Schauer and Kamerling, 1997). So far
Neu5Gc-containing glycolipids have been reported only from
other neoplastic tissues, e.g., melanoma (Nakarai et al, 1990; Saida
et al, 1990), germ cell tumors (Miyake et al, 1990), and invasive
ductal mamma carcinoma (Marquina et al, 1996). We conclude
from the occurrence of these unusual gangliosides in basalioma cells
that they may be considered also in this case as tumor markers, in
addition to 9-O-acetyl-GD3. In accordance with this is the absence
of Neu5Gc in healthy human skin.
It was observed that ¯uorescence intensities of the BCC
surrounding tissue histologically free of tumor cells were
considerably higher than those of normal tissue using the virus
microtiter assay (Fig 1); this suggests a metabolic change already
occurring in the proximity of tumor tissue before microscopic and
macroscopic investigations. This is in accordance with observations
by Heidenheim et al (1995) that higher CDw60 immunoreactivity
also existed in the tumor surroundings and decreased with
increasing distance. Correspondingly, in both virus TLC overlay
and by immunostaining on TLC with MoAb against 9-O-acetyl
GD3 (Fig 3A,B, lane 3), a faint band of O-acetylated GD3 from the
surrounding tissue was visible.
As our primary goal in this study was to evaluate ganglioside-
bound 9-O-acetylation as a possible tumor-speci®c structure, the
in¯uenza C virus assay proved to be a very valuable, speci®c, and
sensitive method, allowing the analysis of individual tumor probes.
This shows that there are great variations in the relative amount of
9-O-acetylated gangliosides (Fig 1), which may be due to
individual tumor differences or to the loss of some O-acetyl
groups during storage of the samples or during ganglioside isolation.
The classic procedures for analysis of the nature of sialic acids
(HPLC, TLC, mass spectrometry) require the previous release of
these monosaccharides from their glycosidic linkage, whereas we
used the in¯uenza C virus to detect directly Neu5,9Ac2 residues on
immobilized gangliosides. Employing both versions of the virus
assay, we found the sensitivity of the microtiter version to be in the
same range, as that observed for HPLC analysis of free sialic acids,
and about 10±20 times greater than that of the TLC overlay version
(Table I). Consequently, the virus microtiter assay may be used in
screening prior to tests with speci®c MoAb.
The results of this study indicate signi®cant changes of ganglio-
side biosynthesis in basalioma cells when compared with normal
human skin. The stage of differentiation and oncogenic transfor-
mation of a cell seems to be re¯ected by an altered ganglioside
pattern. Increasing incidence exists that abnormal cell surface
molecules shield neoplastic cells from the immune system;
however, response to BCC of the skin is still not completely
understood. Elucidating possible tumor-associated antigens may
give better insight into mechanisms of tumor growth and also
provides an additional diagnostic tool as well as a basis for speci®c
immunotherapy, which may contribute to future treatment
strategies.
Furthermore, as sialic acid O-acetylation of gangliosides is
involved in the control of cell growth, investigations on the
regulation of the expression of this sialic acid modi®cation on
enzymatic and molecular genetic levels are necessary. The presence
of three types of sialic acids O-acetylated in their side chain
(Neu5,7Ac2, Neu5,8Ac2, and Neu5,9Ac2) in human basalioma,
which, with the exception of Neu5,8Ac2, were also found in other
human tissues (Schauer and Kamerling, 1997), suggests that the
biosynthesis of these monosaccharides occurs similarly as described
in bovine submandibular gland (Vandamme-Feldhaus and Schauer,
1998). Accordingly, the primary insertion site of the O-acetyl
group by a sialic acid-speci®c O-acetyltransferase is at C7, followed
by migration of this ester group to C8 and C9 (Varki and Diaz,
1984; Kamerling et al, 1987). Therefore, study of this enzyme
reaction in basalioma is currently being carried out.
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